Clinical Trial 47711

Tustin, CA 92780


A phase 1 first in human, randomized, double blind, sponsor open, placebo-controlled, single- and multiple dose escalation, parallel group study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of pf-07242813 in healthy participants and participants with atopic dermatitis.

Qualified Participants Must:

• Age 18 to 65 years old
• BMI between 17.5 and 40
• Have been diagnosed with Eczema (Atopic Dermatitis) for at least one year

Qualified Participants May Receive:

Compensation up to $3100.00

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.